Form D · Biotechnology

Trait Biosciences Inc.

Vancouver, A1 · CIK 0001779238

Offering snapshot reported Sep 25, 2023 · SEC filing

Reported sold
$3.69M
Offering amount: $3.69M
Investors reported
3
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Sep 12, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2023Initial$3,687,316No comparison3SEC filing
Nov 23, 2022Initial$209,849No comparison4SEC filing
Nov 23, 2022Initial$101,934No comparison4SEC filing
Nov 23, 2022Initial$230,073No comparison4SEC filing
Oct 22, 2021Initial$618,750No comparison4SEC filing
Mar 31, 2021Initial$12,081,915No comparison4SEC filing
Aug 1, 2019Initial$7,574,350No comparison4SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-492902
Total Offering Amount was in Canadian Dollars and was $5,000,000. USD is calculated at bank of Canada exchange rate on closing date.

Source: Form D, filed Sep 25, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Del Moral Director
Richard Todd De Rose Executive
Ronald E. Deutsch Executive
Michael Bruce Harrison Director, Executive, Promoter
Eugene Allan Hodgson Executive
Andrew Templeton Hunter Executive
Hanny Kanafani Executive
Kimberly Ann Landry Executive
Ronan David Levy Director
Aristobulo Loaiza Executive
Peter J. Mc Donough Director, Executive
Tichafa Regus Ignatius Munyikwa Executive
David Rosenthal Director
Richard Thomas Sayre Executive, Promoter
David William Smalley Executive
Jay Sweeney Executive
Rebecca White Executive
Tawanda Zidenga Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1600 1111 West Georgia St.
Vancouver, A1, V6E 4G2